Line item 1: sterility (510120GMP.BSV) units: each catalog#: 510120GMP. Pots#14-003562

Ended Awarded Last action

Contract number
HHSN26100002
Awardee
Awarding agency
Obligated
$87,850

Award facts

Opportunity
Contract value 100% obligated
$87,849.55 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Rockville, MD 20850, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00002 -$3,983
Other Administrative Action 1 $0
Original award $91,832

About this award

The National Cancer Institute issued a delivery order to Bioreliance Corporation on November 21, 2013, with a ceiling value of $87,849.55 for sterility testing services (isolator sterility testing, catalog 510120GMP).

Place of performance is Rockville, MD. The order's ultimate completion date was November 20, 2014. Pricing is firm fixed price. This is a child delivery order issued under a parent indefinite delivery contract.

Quick answers

Who was awarded contract HHSN26100002?

HHSN26100002 was awarded to Bioreliance Corporation by National Cancer Institute (National Institutes of Health) on November 21, 2013.

How much is contract HHSN26100002 worth?

The government has obligated $87,850 on HHSN26100002.

Is contract HHSN26100002 an order under another contract?

Yes. HHSN26100002 is a delivery order under HHSN261201300026I, an indefinite delivery contract.

Was contract HHSN26100002 competed?

The extent of competition for HHSN26100002 was competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award